Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBIT ratio high or low?
The EV/EBIT ratio of 12.48x is 33% below its estimated 5-year average of 18.55x, near the low end of its estimated 5-year range (8.54x–31.47x).
As of 2026-10-06T19:50:09.650Z. 15.03% below its estimated 12-month average of 14.69x.
Calculation as of: 2026-10-06T19:50:09.650Z.
Quote observation: 2026-10-06T19:45:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bd1da7b8fdbe91cdca625bc0f024fb4dc004e27004d76598aac54aa781ae1c7d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
12.48x
EV/EBIT RATIO AVG TTM
14.69x
EV/EBIT RATIO AVG 3Y
14.69x
EV/EBIT RATIO AVG 5Y
18.55x
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.03%
CURRENT VS 3Y AVG
-15.03%
CURRENT VS 5Y AVG
-32.74%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
22.67x
median of 197 covered companies
CURRENT VS SECTOR MEDIAN
-44.95%
vs the sector median at left
Zevra Therapeutics, Inc.
Market Cap
$631.35M
EV/EBIT Ratio
12.48x
TTM Avg
14.69x
3Y Avg
14.69x
5Y Avg
18.55x
Market Cap
$656.86M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zevra Therapeutics, Inc. (ZVRA) | $631.35M | 12.48x | 14.69x | 14.69x | 18.55x |
| Aura Biosciences, Inc. (AURA)vs › | $632.49M | N/A | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $633.06M | N/A | N/A | N/A | N/A |
| SOPHiA GENETICS S.A. (SOPH)vs › | $623.06M | N/A | N/A | N/A | N/A |
| OmniAb, Inc. (OABI)vs › | $621.21M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $656.86M | N/A | N/A | N/A | N/A |
| Starling Oncology, Inc. (STLN)vs › | $658.68M | N/A | N/A | N/A | N/A |
| Helus Pharma Inc. (HELP)vs › | $660.17M | N/A | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $598.37M | 3.88x | 7.80x | 8.99x | 8.51x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-10-05 | 13.12x |
| 2026-10-02 | 12.00x |
| 2026-10-01 | 12.30x |
| 2026-09-30 | 13.54x |
| 2026-09-29 | 14.12x |
| 2026-09-28 | 14.06x |
| 2026-09-25 | 13.65x |
| 2026-09-24 | 14.00x |
| 2026-09-23 | 14.09x |
| 2026-09-22 | 14.50x |
| 2026-09-21 | 14.64x |
| 2026-09-18 | 14.55x |
| 2026-09-17 | 14.91x |
| 2026-09-16 | 14.84x |
| 2026-09-15 | 14.61x |
| 2026-09-14 | 15.24x |
| 2026-09-11 | 15.17x |
| 2026-09-10 | 15.25x |
| 2026-09-09 | 15.22x |
| 2026-09-08 | 16.23x |
| 2026-09-04 | 15.79x |
| 2026-09-03 | 16.01x |
| 2026-09-02 | 15.63x |
| 2026-09-01 | 15.25x |
| 2026-08-31 | 14.75x |
| 2026-08-28 | 14.48x |
| 2026-08-27 | 14.92x |
| 2026-08-26 | 14.75x |
| 2026-08-25 | 15.22x |
| 2026-08-24 | 14.61x |
| 2026-08-21 | 14.95x |
| 2026-08-20 | 14.99x |
| 2026-08-19 | 15.36x |
| 2026-08-18 | 14.48x |
| 2026-08-17 | 14.42x |
| 2026-08-14 | 14.09x |
| 2026-08-13 | 13.87x |
| 2026-08-12 | 14.28x |
| 2026-08-11 | 14.12x |
| 2026-08-10 | 14.34x |
| 2026-08-07 | 14.47x |
| 2026-08-06 | 14.97x |
| 2022-03-31 | 8.68x |
| 2022-03-30 | 10.01x |
| 2022-03-29 | 9.82x |
| 2022-03-28 | 9.00x |
| 2022-03-25 | 9.00x |
| 2022-03-24 | 10.28x |
| 2022-03-23 | 8.72x |
| 2022-03-22 | 9.41x |
| 2022-03-21 | 8.82x |
| 2022-03-18 | 10.14x |
| 2022-03-17 | 11.47x |
| 2022-03-16 | 9.87x |
| 2022-03-15 | 9.09x |
| 2022-03-14 | 8.54x |
| 2022-03-11 | 9.59x |
| 2022-03-10 | 10.46x |
| 2022-03-09 | 11.24x |
| 2022-03-08 | 10.19x |
| 2022-03-07 | 10.65x |
| 2022-03-04 | 9.73x |
| 2022-03-03 | 10.60x |
| 2022-03-02 | 12.20x |
| 2022-03-01 | 11.70x |
| 2022-02-28 | 12.80x |
| 2022-02-25 | 12.48x |
| 2022-02-24 | 12.57x |
| 2022-02-23 | 11.01x |
| 2022-02-22 | 11.84x |
| 2022-02-18 | 11.70x |
| 2022-02-17 | 11.47x |
| 2022-02-16 | 13.12x |
| 2022-02-15 | 13.89x |
| 2022-02-14 | 13.53x |
| 2022-02-11 | 13.62x |
| 2022-02-10 | 15.63x |
| 2022-02-09 | 16.04x |
| 2022-02-08 | 15.63x |
| 2022-02-07 | 15.91x |
| 2022-02-04 | 15.63x |
| 2022-02-03 | 15.45x |
| 2022-02-02 | 16.00x |
| 2022-02-01 | 18.47x |
| 2022-01-31 | 18.65x |
| 2022-01-28 | 15.13x |
| 2022-01-27 | 13.89x |
| 2022-01-26 | 15.04x |
| 2022-01-25 | 16.32x |
| 2022-01-24 | 16.09x |
| 2022-01-21 | 15.31x |
| 2022-01-20 | 17.83x |
| 2022-01-19 | 20.80x |
| 2022-01-18 | 22.26x |
| 2022-01-14 | 23.13x |
| 2022-01-13 | 22.95x |
| 2022-01-12 | 24.69x |
| 2022-01-11 | 26.06x |
| 2022-01-10 | 25.05x |
| 2022-01-07 | 25.14x |
| 2022-01-06 | 24.09x |
| 2022-01-05 | 23.86x |
| 2022-01-04 | 25.74x |
| 2022-01-03 | 28.03x |
| 2021-12-31 | 24.05x |
| 2021-12-30 | 25.30x |
| 2021-12-29 | 25.82x |
| 2021-12-28 | 23.43x |
| 2021-12-27 | 26.93x |
| 2021-12-23 | 25.30x |
| 2021-12-22 | 24.53x |
| 2021-12-21 | 24.96x |
| 2021-12-20 | 22.14x |
| 2021-12-17 | 19.60x |
| 2021-12-16 | 18.74x |
| 2021-12-15 | 19.98x |
| 2021-12-14 | 19.03x |
| 2021-12-13 | 19.55x |
| 2021-12-10 | 22.76x |
| 2021-12-09 | 23.91x |
| 2021-12-08 | 24.34x |
| 2021-12-07 | 22.86x |
| 2021-12-06 | 21.28x |
| 2021-12-03 | 19.31x |
| 2021-12-02 | 21.71x |
| 2021-12-01 | 20.80x |
| 2021-11-30 | 19.84x |
| 2021-11-29 | 19.98x |
| 2021-11-26 | 20.89x |
| 2021-11-24 | 21.99x |
| 2021-11-23 | 21.85x |
| 2021-11-22 | 21.28x |
| 2021-11-19 | 22.57x |
| 2021-11-18 | 22.04x |
| 2021-11-17 | 22.33x |
| 2021-11-16 | 25.15x |
| 2021-11-15 | 26.25x |
| 2021-11-12 | 26.02x |
| 2021-11-11 | 27.16x |
| 2021-11-10 | 25.92x |
| 2021-11-09 | 27.21x |
| 2021-11-08 | 27.36x |
| 2021-11-05 | 27.64x |
| 2021-11-04 | 28.31x |
| 2021-11-03 | 28.07x |
| 2021-11-02 | 29.22x |
| 2021-11-01 | 28.27x |
| 2021-10-29 | 27.83x |
| 2021-10-28 | 30.47x |
| 2021-10-27 | 30.71x |
| 2021-10-26 | 31.47x |
| 2021-10-25 | 29.70x |
| 2021-10-22 | 30.66x |
| 2021-10-21 | 28.98x |
| 2021-10-20 | 30.32x |
| 2021-10-19 | 28.74x |
| 2021-10-18 | 27.36x |
| 2021-10-15 | 29.13x |
| 2021-10-14 | 29.03x |
| 2021-10-13 | 29.08x |
| 2021-10-12 | 28.94x |
| 2021-10-11 | 25.73x |
| 2021-10-08 | 24.34x |
| 2021-10-07 | 24.72x |
| 2021-10-06 | 24.20x |
| 2021-10-05 | 24.96x |
| 2021-10-04 | 25.49x |
| 2021-10-01 | 26.83x |
| 2021-09-30 | 16.94x |
| 2021-09-29 | 16.31x |
| 2021-09-28 | 16.52x |
| 2021-09-27 | 17.53x |
| 2021-09-24 | 16.14x |
| 2021-09-23 | 16.83x |
| 2021-09-22 | 15.06x |
| 2021-09-21 | 15.68x |
| 2021-09-20 | 14.81x |
| 2021-09-17 | 16.07x |
| 2021-09-16 | 15.58x |
| 2021-09-15 | 15.16x |
| 2021-09-14 | 14.81x |
| 2021-09-13 | 15.72x |
| 2021-09-10 | 16.76x |
| 2021-09-09 | 16.59x |
| 2021-09-08 | 15.65x |
| 2021-09-07 | 16.31x |
| 2021-09-03 | 17.85x |
| 2021-09-02 | 17.18x |
| 2021-09-01 | 16.14x |
| 2021-08-31 | 16.83x |
| 2021-08-30 | 15.47x |
| 2021-08-27 | 15.37x |
| 2021-08-26 | 15.40x |
| 2021-08-25 | 16.49x |
| 2021-08-24 | 17.81x |
| 2021-08-23 | 16.73x |
| 2021-08-20 | 16.00x |
| 2021-08-19 | 15.44x |
| 2021-08-18 | 16.56x |
| 2021-08-17 | 16.90x |
| 2021-08-16 | 15.47x |
| 2021-08-13 | 16.14x |
| 2021-08-12 | 19.94x |
| 2021-08-11 | 19.41x |
| 2021-08-10 | 19.38x |
| 2021-08-09 | 20.08x |
| 2021-08-06 | 18.82x |
| 2021-08-05 | 18.51x |
| 2021-08-04 | 18.30x |
| 2021-08-03 | 18.89x |
| 2021-08-02 | 20.32x |
| 2021-07-30 | 19.59x |
| 2021-07-29 | 20.36x |
| 2021-07-28 | 22.73x |
| 2021-07-27 | 21.93x |
| 2021-07-26 | 21.89x |
| 2021-07-23 | 21.89x |
| 2021-07-22 | 22.73x |
| 2021-07-21 | 24.02x |
| 2021-07-20 | 23.18x |
| 2021-07-19 | 22.03x |
| 2021-07-16 | 22.73x |
| 2021-07-15 | 23.81x |
| 2021-07-14 | 24.99x |
| 2021-07-13 | 26.81x |
| 2021-07-12 | 30.50x |
| 2021-07-09 | 30.82x |
| 2021-07-08 | 29.60x |
| 2021-07-07 | 28.66x |
| 2021-07-06 | 29.00x |
| 2021-07-02 | 29.56x |
| 2021-07-01 | 30.82x |
| 2021-06-30 | 33.61x |
| 2021-06-29 | 34.99x |
| 2021-06-28 | 35.03x |
| 2021-06-25 | 39.03x |
| 2021-06-24 | 38.95x |
| 2021-06-23 | 39.14x |
| 2021-06-22 | 38.35x |
| 2021-06-21 | 38.28x |
| 2021-06-18 | 37.76x |
| 2021-06-17 | 43.51x |
| 2021-06-16 | 41.87x |
| 2021-06-15 | 41.75x |
| 2021-06-14 | 39.51x |
| 2021-06-11 | 40.33x |
| 2021-06-10 | 35.59x |
| 2021-06-09 | 32.34x |
| 2021-06-08 | 31.33x |
| 2021-06-07 | 30.85x |
| 2021-06-04 | 28.01x |
| 2021-06-03 | 27.19x |
| 2021-06-02 | 25.47x |
| 2021-06-01 | 26.33x |
| 2021-05-28 | 23.97x |
| 2021-05-27 | 23.26x |
| 2021-05-26 | 22.55x |
| 2021-05-25 | 23.11x |
| 2021-05-24 | 23.23x |
| 2021-05-21 | 22.74x |
Showing the most recent 260 of 295 data points. The chart above shows the full history.
